NYSE:GSK
GlaxoSmithKline Stock News
$44.98
+0.1000 (+0.223%)
At Close: May 17, 2024
GlaxoSmithKline goes ex-dividend tomorrow
03:12pm, Wednesday, 17'th Nov 2021 Seeking AlphaUS Government Agrees To Purchase GSK-Vir Biotech''s COVID-19 Antibody Doses Worth $1B
02:54pm, Wednesday, 17'th Nov 2021 Benzinga
The United States government has signed contracts worth about $1 billion to secure the antibody-based COVID-19 treatment developed by GlaxoSmithKline plc (NYSE: GSK ) and Vir Biotechnology Inc (NASDAQ: VIR ). GSK said the deal brought the total number of doses secured for the treatment, sotrovimab, to more than 750,000 globally. The U.S. deliveries of sotrovimab are expected by … Full story available on Benzinga.com
Robitussin Teams Up with Tony Award-Winning Actress, Adrienne Warren, to Help Increase Access to the Performing Arts in Underserved Communities
02:07pm, Wednesday, 17'th Nov 2021 PR Newswire
WARREN, N.J., Nov. 17, 2021 /PRNewswire/ -- GSK Consumer Healthcare''s (LSE/NYSE: GSK) Robitussin brand today announced a partnership with the All Stars Project, Inc. to help provide access to performing arts education for youth in underserved communities. Robitussin believes that everyone
Stocks making the biggest moves premarket: Lowe''s, Target, GlaxoSmithKline and others
12:46pm, Wednesday, 17'th Nov 2021 CNBC
These are the stocks posting the largest moves before the bell.
Artificial Saliva Market Size 2021, Global Industry Analysis, Segments, Drivers and Trends to 2027|GlaxoSmithKline, Cipla Limited, Fresenius Kabi
12:05pm, Wednesday, 17'th Nov 2021 OpenPR
The global Artificial Saliva market will grow at a CAGR of 8.42% from 2021 to 2027. Artificial saliva is used in the treatment of dry mouth. The rising incidents of cancer and a higher need for its treatments such as
US to buy more GSK doses for $651M - report
11:24am, Wednesday, 17'th Nov 2021 Breaking the News 24/7
The United States government has signed a contract for a further 300,000 doses of GlaxoSmithKline''s (GSK) sotrovimab COVID-19 antibody drug, according to a source quoted by the Wall Street Journal
Covid breakthrough as UK''s GlaxoSmithKline strikes $1bn wonder drug deal with US
10:23am, Wednesday, 17'th Nov 2021 Daily Express
A COVID-19 BREAKTHROUGH has been made as UK drugmaker GlaxoSmithKline has signed a huge $1billion deal with US-based Vir Biotechnology.
DNA Vaccines Market research report has been produced with the systematic gathering of market information for industry. All this information is supplied in such a way that it properly gives explanation of various facts and figures to the business.
GlaxoSmithKline plc (NYSE:GSK) Raises Dividend to $0.52 Per Share
03:36pm, Tuesday, 16'th Nov 2021 Dakota Financial News
GlaxoSmithKline plc (NYSE:GSK) announced a quarterly dividend on Friday, October 29th, Wall Street Journal reports. Shareholders of record on Friday, November 19th will be paid a dividend of 0.5234 per share by the pharmaceutical company on Thursday, January 13th. This represents a $2.09 dividend on an annualized basis and a dividend yield of 4.85%. The []
Human Rotavirus Vaccine Market Qualitative Insights Key Enhancement & Share Analysis to 2027|Bharat Biotech, Merck, GlaxoSmithKline
01:49pm, Tuesday, 16'th Nov 2021 OpenPR
Rotavirus vaccine is applied to prevent against rotavirus infections which can cause severe diarrhoea amongst young children. Symptoms of rotavirus infection consist of severe diarrhoea, vomiting, fever, and abdominal pain which can cause the disease. Rotavirus vaccine is given by
GlaxoSmithKline plc (GSK) to Issue Dividend of GBX 19 on January 13th
01:48pm, Tuesday, 16'th Nov 2021 Dakota Financial News
GlaxoSmithKline plc (LON:GSK) announced a dividend on Wednesday, October 27th, Upcoming.Co.Uk reports. Stockholders of record on Thursday, November 18th will be paid a dividend of GBX 19 ($0.25) per share on Thursday, January 13th. This represents a dividend yield of 1.32%. The ex-dividend date of this dividend is Thursday, November 18th. The official announcement can []
The sexually transmitted diseases (STDs) denotes to a varied clinical syndromes and infections initiated by pathogens that can be developed and spread through sexual activity. The STDs are detected through various tests such as physical examination or assays, rapid plasma
Palmer Hyperhidrosis Treatment Market Research Report (2021-2027): Key Trends and Opportunities |Allergan, GlaxoSmithKline, Revance Therapeutics
09:54am, Tuesday, 16'th Nov 2021 OpenPR
Hyperhidrosis is a disorder that results in excessive sweating of palms, soles, or underarms. Palmer hyperhidrosis is excessive and uncontrollable hand sweating and is the most common type of hyperhidrosis. The sweating may range from mild to severe. Market Snapshot
Systemic Lupus Erythematosus Treatment Market to Witness an Outstanding Growth by 2027| GlaxoSmithKline, F. Hoffmann-La Roche, Pfizer
09:26am, Tuesday, 16'th Nov 2021 OpenPR
Market Snapshot A recently published report by QY Research, titled Global Systemic Lupus Erythematosus Treatment Market Size, Status and Forecast 2022 gives an overview of the overall Systemic Lupus Erythematosus Treatment market. This section sheds light on key impact-rendering drivers